Get Real Time Here
| Day Range1.250 - 1.420 | 52 Wk Range0 - 3.630 | Open / Close1.310 / - | Float / Outstanding- / 22.594M |
| Vol / Avg.40.027K / 1.446M | Mkt Cap30.581M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.300 |
Celyad Oncology Stock (NASDAQ:CYAD), Quotes and News Summary
Celyad Oncology Stock (NASDAQ: CYAD) stock price, news, charts, stock research, profile.
| Day Range1.250 - 1.420 | 52 Wk Range0 - 3.630 | Open / Close1.310 / - | Float / Outstanding- / 22.594M |
| Vol / Avg.40.027K / 1.446M | Mkt Cap30.581M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.300 |
Earnings
see more| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-04-09 | ||||||
| REV | |||||||
| H1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.660 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celyad Oncology (CYAD) stock?
You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.
Who are Celyad Oncology's (CYAD) competitors?
Other companies in Celyad Oncology’s space includes: Vincerx Pharma (NASDAQ:VINC), Aeglea BioTherapeutics (NASDAQ:AGLE), Comera Life Sciences (NASDAQ:CMRA), Lumos Pharma (NASDAQ:LUMO) and Harpoon Therapeutics (NASDAQ:HARP).
What is the target price for Celyad Oncology (CYAD) stock?
The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by Wells Fargo on Tuesday, January 11, 2022. The analyst firm set a price target for 11.00 expecting CYAD to rise to within 12 months (a possible 712.71% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Celyad Oncology (CYAD)?
The stock price for Celyad Oncology (NASDAQ: CYAD) is $1.3535 last updated Today at February 1, 2023 at 7:42 PM UTC.
Does Celyad Oncology (CYAD) pay a dividend?
There are no upcoming dividends for Celyad Oncology.
When is Celyad Oncology (NASDAQ:CYAD) reporting earnings?
Celyad Oncology’s FY earnings are confirmed for Sunday, April 9, 2023.
Is Celyad Oncology (CYAD) going to split?
There is no upcoming split for Celyad Oncology.
What sector and industry does Celyad Oncology (CYAD) operate in?
Celyad Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celyad Oncology Stock (NASDAQ:CYAD), Quotes and News Summary
Celyad Oncology Stock (NASDAQ: CYAD) stock price, news, charts, stock research, profile.
| Day Range1.250 - 1.420 | 52 Wk Range0 - 3.630 | Open / Close1.310 / - | Float / Outstanding- / 22.594M |
| Vol / Avg.40.027K / 1.446M | Mkt Cap30.581M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.300 |
Earnings
see more| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-04-09 | ||||||
| REV | |||||||
| H1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.660 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celyad Oncology (CYAD) stock?
You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.
Who are Celyad Oncology's (CYAD) competitors?
Other companies in Celyad Oncology’s space includes: Vincerx Pharma (NASDAQ:VINC), Aeglea BioTherapeutics (NASDAQ:AGLE), Comera Life Sciences (NASDAQ:CMRA), Lumos Pharma (NASDAQ:LUMO) and Harpoon Therapeutics (NASDAQ:HARP).
What is the target price for Celyad Oncology (CYAD) stock?
The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by Wells Fargo on Tuesday, January 11, 2022. The analyst firm set a price target for 11.00 expecting CYAD to rise to within 12 months (a possible 712.71% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Celyad Oncology (CYAD)?
The stock price for Celyad Oncology (NASDAQ: CYAD) is $1.3535 last updated Today at February 1, 2023 at 7:42 PM UTC.
Does Celyad Oncology (CYAD) pay a dividend?
There are no upcoming dividends for Celyad Oncology.
When is Celyad Oncology (NASDAQ:CYAD) reporting earnings?
Celyad Oncology’s FY earnings are confirmed for Sunday, April 9, 2023.
Is Celyad Oncology (CYAD) going to split?
There is no upcoming split for Celyad Oncology.
What sector and industry does Celyad Oncology (CYAD) operate in?
Celyad Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celyad Oncology Stock (NASDAQ:CYAD), Quotes and News Summary
Celyad Oncology Stock (NASDAQ: CYAD) stock price, news, charts, stock research, profile.
| Day Range1.250 - 1.420 | 52 Wk Range0 - 3.630 | Open / Close1.310 / - | Float / Outstanding- / 22.594M |
| Vol / Avg.40.027K / 1.446M | Mkt Cap30.581M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.300 |
Earnings
see more| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-04-09 | ||||||
| REV | |||||||
| H1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.660 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celyad Oncology (CYAD) stock?
You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.
Who are Celyad Oncology's (CYAD) competitors?
Other companies in Celyad Oncology’s space includes: Vincerx Pharma (NASDAQ:VINC), Aeglea BioTherapeutics (NASDAQ:AGLE), Comera Life Sciences (NASDAQ:CMRA), Lumos Pharma (NASDAQ:LUMO) and Harpoon Therapeutics (NASDAQ:HARP).
What is the target price for Celyad Oncology (CYAD) stock?
The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by Wells Fargo on Tuesday, January 11, 2022. The analyst firm set a price target for 11.00 expecting CYAD to rise to within 12 months (a possible 712.71% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Celyad Oncology (CYAD)?
The stock price for Celyad Oncology (NASDAQ: CYAD) is $1.3535 last updated Today at February 1, 2023 at 7:42 PM UTC.
Does Celyad Oncology (CYAD) pay a dividend?
There are no upcoming dividends for Celyad Oncology.
When is Celyad Oncology (NASDAQ:CYAD) reporting earnings?
Celyad Oncology’s FY earnings are confirmed for Sunday, April 9, 2023.
Is Celyad Oncology (CYAD) going to split?
There is no upcoming split for Celyad Oncology.
What sector and industry does Celyad Oncology (CYAD) operate in?
Celyad Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celyad Oncology Stock (NASDAQ:CYAD), Quotes and News Summary
Celyad Oncology Stock (NASDAQ: CYAD) stock price, news, charts, stock research, profile.
| Day Range1.250 - 1.420 | 52 Wk Range0 - 3.630 | Open / Close1.310 / - | Float / Outstanding- / 22.594M |
| Vol / Avg.40.027K / 1.446M | Mkt Cap30.581M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.300 |
Earnings
see more| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-04-09 | ||||||
| REV | |||||||
| H1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.660 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celyad Oncology (CYAD) stock?
You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.
Who are Celyad Oncology's (CYAD) competitors?
Other companies in Celyad Oncology’s space includes: Vincerx Pharma (NASDAQ:VINC), Aeglea BioTherapeutics (NASDAQ:AGLE), Comera Life Sciences (NASDAQ:CMRA), Lumos Pharma (NASDAQ:LUMO) and Harpoon Therapeutics (NASDAQ:HARP).
What is the target price for Celyad Oncology (CYAD) stock?
The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by Wells Fargo on Tuesday, January 11, 2022. The analyst firm set a price target for 11.00 expecting CYAD to rise to within 12 months (a possible 712.71% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Celyad Oncology (CYAD)?
The stock price for Celyad Oncology (NASDAQ: CYAD) is $1.3535 last updated Today at February 1, 2023 at 7:42 PM UTC.
Does Celyad Oncology (CYAD) pay a dividend?
There are no upcoming dividends for Celyad Oncology.
When is Celyad Oncology (NASDAQ:CYAD) reporting earnings?
Celyad Oncology’s FY earnings are confirmed for Sunday, April 9, 2023.
Is Celyad Oncology (CYAD) going to split?
There is no upcoming split for Celyad Oncology.
What sector and industry does Celyad Oncology (CYAD) operate in?
Celyad Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celyad Oncology Stock (NASDAQ:CYAD), Quotes and News Summary
Celyad Oncology Stock (NASDAQ: CYAD) stock price, news, charts, stock research, profile.
| Day Range1.250 - 1.420 | 52 Wk Range0 - 3.630 | Open / Close1.310 / - | Float / Outstanding- / 22.594M |
| Vol / Avg.40.027K / 1.446M | Mkt Cap30.581M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.300 |
Earnings
see more| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-04-09 | ||||||
| REV | |||||||
| H1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.660 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celyad Oncology (CYAD) stock?
You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.
Who are Celyad Oncology's (CYAD) competitors?
Other companies in Celyad Oncology’s space includes: Vincerx Pharma (NASDAQ:VINC), Aeglea BioTherapeutics (NASDAQ:AGLE), Comera Life Sciences (NASDAQ:CMRA), Lumos Pharma (NASDAQ:LUMO) and Harpoon Therapeutics (NASDAQ:HARP).
What is the target price for Celyad Oncology (CYAD) stock?
The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by Wells Fargo on Tuesday, January 11, 2022. The analyst firm set a price target for 11.00 expecting CYAD to rise to within 12 months (a possible 712.71% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Celyad Oncology (CYAD)?
The stock price for Celyad Oncology (NASDAQ: CYAD) is $1.3535 last updated Today at February 1, 2023 at 7:42 PM UTC.
Does Celyad Oncology (CYAD) pay a dividend?
There are no upcoming dividends for Celyad Oncology.
When is Celyad Oncology (NASDAQ:CYAD) reporting earnings?
Celyad Oncology’s FY earnings are confirmed for Sunday, April 9, 2023.
Is Celyad Oncology (CYAD) going to split?
There is no upcoming split for Celyad Oncology.
What sector and industry does Celyad Oncology (CYAD) operate in?
Celyad Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celyad Oncology Stock (NASDAQ:CYAD), Quotes and News Summary
Celyad Oncology Stock (NASDAQ: CYAD) stock price, news, charts, stock research, profile.
| Day Range1.250 - 1.420 | 52 Wk Range0 - 3.630 | Open / Close1.310 / - | Float / Outstanding- / 22.594M |
| Vol / Avg.40.027K / 1.446M | Mkt Cap30.581M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.300 |
Earnings
see more| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-04-09 | ||||||
| REV | |||||||
| H1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.660 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celyad Oncology (CYAD) stock?
You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.
Who are Celyad Oncology's (CYAD) competitors?
Other companies in Celyad Oncology’s space includes: Vincerx Pharma (NASDAQ:VINC), Aeglea BioTherapeutics (NASDAQ:AGLE), Comera Life Sciences (NASDAQ:CMRA), Lumos Pharma (NASDAQ:LUMO) and Harpoon Therapeutics (NASDAQ:HARP).
What is the target price for Celyad Oncology (CYAD) stock?
The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by Wells Fargo on Tuesday, January 11, 2022. The analyst firm set a price target for 11.00 expecting CYAD to rise to within 12 months (a possible 712.71% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Celyad Oncology (CYAD)?
The stock price for Celyad Oncology (NASDAQ: CYAD) is $1.3535 last updated Today at February 1, 2023 at 7:42 PM UTC.
Does Celyad Oncology (CYAD) pay a dividend?
There are no upcoming dividends for Celyad Oncology.
When is Celyad Oncology (NASDAQ:CYAD) reporting earnings?
Celyad Oncology’s FY earnings are confirmed for Sunday, April 9, 2023.
Is Celyad Oncology (CYAD) going to split?
There is no upcoming split for Celyad Oncology.
What sector and industry does Celyad Oncology (CYAD) operate in?
Celyad Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celyad Oncology Stock (NASDAQ:CYAD), Quotes and News Summary
Celyad Oncology Stock (NASDAQ: CYAD) stock price, news, charts, stock research, profile.
| Day Range1.250 - 1.420 | 52 Wk Range0 - 3.630 | Open / Close1.310 / - | Float / Outstanding- / 22.594M |
| Vol / Avg.40.027K / 1.446M | Mkt Cap30.581M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.300 |
Earnings
see more| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-04-09 | ||||||
| REV | |||||||
| H1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.660 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celyad Oncology (CYAD) stock?
You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.
Who are Celyad Oncology's (CYAD) competitors?
Other companies in Celyad Oncology’s space includes: Vincerx Pharma (NASDAQ:VINC), Aeglea BioTherapeutics (NASDAQ:AGLE), Comera Life Sciences (NASDAQ:CMRA), Lumos Pharma (NASDAQ:LUMO) and Harpoon Therapeutics (NASDAQ:HARP).
What is the target price for Celyad Oncology (CYAD) stock?
The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by Wells Fargo on Tuesday, January 11, 2022. The analyst firm set a price target for 11.00 expecting CYAD to rise to within 12 months (a possible 712.71% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Celyad Oncology (CYAD)?
The stock price for Celyad Oncology (NASDAQ: CYAD) is $1.3535 last updated Today at February 1, 2023 at 7:42 PM UTC.
Does Celyad Oncology (CYAD) pay a dividend?
There are no upcoming dividends for Celyad Oncology.
When is Celyad Oncology (NASDAQ:CYAD) reporting earnings?
Celyad Oncology’s FY earnings are confirmed for Sunday, April 9, 2023.
Is Celyad Oncology (CYAD) going to split?
There is no upcoming split for Celyad Oncology.
What sector and industry does Celyad Oncology (CYAD) operate in?
Celyad Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celyad Oncology Stock (NASDAQ:CYAD), Quotes and News Summary
Celyad Oncology Stock (NASDAQ: CYAD) stock price, news, charts, stock research, profile.
| Day Range1.250 - 1.420 | 52 Wk Range0 - 3.630 | Open / Close1.310 / - | Float / Outstanding- / 22.594M |
| Vol / Avg.40.027K / 1.446M | Mkt Cap30.581M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.300 |
Earnings
see more| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-04-09 | ||||||
| REV | |||||||
| H1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.660 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celyad Oncology (CYAD) stock?
You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.
Who are Celyad Oncology's (CYAD) competitors?
Other companies in Celyad Oncology’s space includes: Vincerx Pharma (NASDAQ:VINC), Aeglea BioTherapeutics (NASDAQ:AGLE), Comera Life Sciences (NASDAQ:CMRA), Lumos Pharma (NASDAQ:LUMO) and Harpoon Therapeutics (NASDAQ:HARP).
What is the target price for Celyad Oncology (CYAD) stock?
The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by Wells Fargo on Tuesday, January 11, 2022. The analyst firm set a price target for 11.00 expecting CYAD to rise to within 12 months (a possible 712.71% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Celyad Oncology (CYAD)?
The stock price for Celyad Oncology (NASDAQ: CYAD) is $1.3535 last updated Today at February 1, 2023 at 7:42 PM UTC.
Does Celyad Oncology (CYAD) pay a dividend?
There are no upcoming dividends for Celyad Oncology.
When is Celyad Oncology (NASDAQ:CYAD) reporting earnings?
Celyad Oncology’s FY earnings are confirmed for Sunday, April 9, 2023.
Is Celyad Oncology (CYAD) going to split?
There is no upcoming split for Celyad Oncology.
What sector and industry does Celyad Oncology (CYAD) operate in?
Celyad Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celyad Oncology Stock (NASDAQ:CYAD), Quotes and News Summary
Celyad Oncology Stock (NASDAQ: CYAD) stock price, news, charts, stock research, profile.
| Day Range1.250 - 1.420 | 52 Wk Range0 - 3.630 | Open / Close1.310 / - | Float / Outstanding- / 22.594M |
| Vol / Avg.40.027K / 1.446M | Mkt Cap30.581M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.300 |
Earnings
see more| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-04-09 | ||||||
| REV | |||||||
| H1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.660 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celyad Oncology (CYAD) stock?
You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.
Who are Celyad Oncology's (CYAD) competitors?
Other companies in Celyad Oncology’s space includes: Vincerx Pharma (NASDAQ:VINC), Aeglea BioTherapeutics (NASDAQ:AGLE), Comera Life Sciences (NASDAQ:CMRA), Lumos Pharma (NASDAQ:LUMO) and Harpoon Therapeutics (NASDAQ:HARP).
What is the target price for Celyad Oncology (CYAD) stock?
The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by Wells Fargo on Tuesday, January 11, 2022. The analyst firm set a price target for 11.00 expecting CYAD to rise to within 12 months (a possible 712.71% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Celyad Oncology (CYAD)?
The stock price for Celyad Oncology (NASDAQ: CYAD) is $1.3535 last updated Today at February 1, 2023 at 7:42 PM UTC.
Does Celyad Oncology (CYAD) pay a dividend?
There are no upcoming dividends for Celyad Oncology.
When is Celyad Oncology (NASDAQ:CYAD) reporting earnings?
Celyad Oncology’s FY earnings are confirmed for Sunday, April 9, 2023.
Is Celyad Oncology (CYAD) going to split?
There is no upcoming split for Celyad Oncology.
What sector and industry does Celyad Oncology (CYAD) operate in?
Celyad Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.